Search Results - (Author, Cooperation:H. Mo)
-
1Staff View
Publication Date: 2018-01-31Publisher: Wiley-BlackwellPrint ISSN: 0148-0227Topics: GeosciencesPhysicsPublished by: -
2Staff View
Publication Date: 2018-06-02Publisher: Institute of Physics (IOP)Print ISSN: 1674-1137Topics: PhysicsPublished by: -
3Staff View
Publication Date: 2018-02-12Publisher: Institute of Physics (IOP)Print ISSN: 1674-1137Topics: PhysicsPublished by: -
4Staff View
Publication Date: 2018-07-27Publisher: Institute of Physics (IOP)Print ISSN: 1674-1137Topics: PhysicsPublished by: -
5J. K. Weng ; Y. Li ; H. Mo ; C. Chapple
American Association for the Advancement of Science (AAAS)
Published 2012Staff ViewPublication Date: 2012-08-28Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsKeywords: Amino Acid Sequence ; Arabidopsis/enzymology/genetics/*metabolism ; Arabidopsis Proteins/chemistry/genetics/*metabolism ; Base Sequence ; Biosynthetic Pathways ; Catalytic Domain ; Cytochrome P-450 Enzyme System/chemistry/genetics/*metabolism ; Dioxygenases/genetics/metabolism ; Evolution, Molecular ; Gene Duplication ; Genome, Plant ; Models, Molecular ; Molecular Sequence Data ; Mutation ; Phenylalanine/metabolism ; Phylogeny ; Plant Stems/metabolism ; Plants, Genetically Modified ; Pyrones/chemistry/*metabolismPublished by: -
6Huang, J., Xu, B., Mo, H., Zhang, W., Chen, X., Wu, D., Qu, D., Wang, X., Lan, B., Yang, B., Wang, P., Zhang, H., Yang, Q., Jiao, Y.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-03-16Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
7Budhani, R. C. ; Tzeng, Sing-Mo H. ; Doerr, H. J. ; Bunshah, R. F.
Woodbury, NY : American Institute of Physics (AIP)
Published 1987Staff ViewISSN: 1077-3118Source: AIP Digital ArchiveTopics: PhysicsNotes: A screen printing method has been used to deposit superconducting films of Y-Ba-Cu-O materials on Al2O3 substrates. The electrical resistivity, microstructure, and adhesion of these films are highly sensitive to the post-printing heat treatment. Films heat treated at 950 °C and below are poorly adherent, whereas those annealed above 1000 °C undergo phase separation to Y2Cu2O5 and BaCuO2 and also react with the substrate. Nearly single phase, highly adherent, and smooth films showing a zero resistance state at 79 K have been synthesized by optimizing the annealing conditions.Type of Medium: Electronic ResourceURL: -
8Mjøs, O. D. ; Vik-Mo, H. ; Gutteberg, T. J. ; Strømme, J. H.
Oxford, UK : Blackwell Publishing Ltd
Published 1977Staff ViewISSN: 1440-1681Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: 1. Dopamine-β-hydroxylase (DβH) activity was measured in sera from ten healthy male students after 2 and 3 days fasting which is associated with increased circulating noradrenaline.2. Circulating DβH remained essentially unchanged throughout the fasting period, although ‘stress parameters’ like plasma glycerol and free fatty acid concentrations were elevated by a factor of about two from first to second and third day of fasting (P〈.0.01).3. Serum DβH activity is not a sensitive index of increased sympathoadrenal activity in fasting man.Type of Medium: Electronic ResourceURL: -
9Staff View
ISSN: 0014-5793Keywords: Mass spectrometry (Human lung) Ganglioside GT3Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: BiologyChemistry and PharmacologyPhysicsType of Medium: Electronic ResourceURL: -
10Staff View
ISSN: 0022-2828Keywords: FFA ; Lipid droplets ; Microspheres ; Morphometric analysis ; Myocardial infarction ; NEFA ; Plasma fatty acidsSource: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: MedicineType of Medium: Electronic ResourceURL: -
11Staff View
ISSN: 0022-2828Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: MedicineType of Medium: Electronic ResourceURL: -
12Staff View
ISSN: 1432-1084Keywords: Key words: Contrast medium ; Iopentol ; Metrizoate ; Haemodynamics ; Left ventricular functionSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract. The aim of the study was to evaluate and compare the hemodynamic and electrocardiographic effects following injection of the non-ionic, low- osmolar contrast medium iopentol (Imagopaque® 350, Nycomed Imaging AS, Oslo, Norway) and the ionic, hyper-osmolar contrast medium metrizoate meglumine-Na-Ca (Isopaque® Coronar 370, Nycomed Imaging AS, Oslo, Norway) when used for left ventricular angiography. The study was performed in a double-blind, randomized manner in 82 patients with severe coronary heart disease. The patients who received iopentol experienced less adverse events and subjective discomfort of lesser intensity than those who received metrizoate (p = 0.0001). Both contrast media induced a biphasic change in left ventricular (LV) systolic pressure, with an initial fall followed by a prolonged rise, but the alterations were statistically significantly more pronounced with metrizoate than with iopentol. The changes in LV end-diastolic pressure (p = 0.023), and LV negative dP/dt (p = 0.002) were significantly more pronounced with metrizoate than with iopentol. Cardiac output and heart rate increased more with metrizoate, while stroke volume was equally increased by both agents. A prolonged increase in the QT-interval, throughout the 10-min observation period, was seen only after injection of metrizoate (p = 0.0006 for comparison between contrast media). Conclusion: Iopentol was well tolerated and induced markedly less severe hemodynamic and electrocardiographic alterations than did metrizoate in patients with severe coronary heart disease.Type of Medium: Electronic ResourceURL: -
13Staff View
ISSN: 1432-1971Keywords: Right ventricle ; Echocardiography ; Angiography ; Atrial septal defectSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract A comparative study of right ventricular (RV) function, assessed by echocardiography and angiography, undertaken in 20 patients, 10 of whom had atrial septal defects (ASDs) and 10 had various other heart diseases. All of the measured echocardiographic variables of RV size, apart from RV length, were larger in the patients with ASD. When assessed by multiple regression analysis, the RV M-mode dimension was an independent variable of RV angiographic end-diastolic volume (EDV) in patients without RV volume load (R=0.92,R 2=0.85,p〈0.001). In the patients with ASD, echocardiographic RV end-diastolic area was an independent variable of angiographic RVEDV (R=0.75,R 2=0.55,p〈0.05), whereas M-mode dimension had a weaker correlation (r=0.29). The agreement between RV ejection fraction (RVEF) obtained by echocardiography and angiography was moderate in both patient groups. However, fractional area change and fractional length change could not estimate RVEF better. Thus care should be taken to use single measurements and derivatives as the only parameters of RV size and function.Type of Medium: Electronic ResourceURL: -
14Staff View
ISSN: 1572-946XSource: Springer Online Journal Archives 1860-2000Topics: PhysicsNotes: Abstract A simulation of accretion of a string loop has been done. It shows that aspherical accretion is essential for large-scale loops. All configurations found in the distribution of galaxies, such as filaments, pancakes, bubbles, and voids, can be formed by the accretion of cosmic strings.Type of Medium: Electronic ResourceURL: -
15Staff View
ISSN: 1439-0973Source: Springer Online Journal Archives 1860-2000Topics: MedicineDescription / Table of Contents: Zusammenfassung Die Pharmakokinetik von Tabletten mit einer Kombination von Sulphadiazin (SDZ) und Trimethoprim (TMP-Co-trimazin) und von Tabletten mit Sulphamethoxazol (SMZ) und TMP (Co-trimoxazol) wurde bei Patienten mit unterschiedlicher Nierenfunktion verglichen. Bei normaler Nierenfunktion gleicht die Pharmakokinetik von SMZ mehr der von TMP als bei Nierenfunktionsstörungen. Obwohl die Serumhalbwertzeit (t1/2) sowohl von aktivem wie vom Gesamt-SDZ derjenigen von TMP ähnlich bleibt, wird der t1/2 Wert des SMZ bei Nierenfunktionsstörungen um ein Mehrfaches höher als der von TMP. Das unveränderte SMZ behält annähernd dieselbe Eliminationsgeschwindigkeit bei eingeschränkter wie bei normaler Nierenfunktion. Folglich sammeln sich bei Co-trimoxazol SMZ Metaboliten an, die nur zur Toxizität von Co-trimoxazol beitragen können, während die Co-trimazin Komponenten bei Nierenfunktionsstörungen t1/2 Werte im gleichen Bereich behalten. Die Verteilungsvolumina von SDZ, SMZ oder TMP sind dieselben, unabhängig von der Nierenfunktion. Jedoch liegt das Verteilungsvolumen von SDZ näher bei dem, von TMP, das heißt, es ist größer als das von SMZ. Sowohl bei normaler als auch bei eingeschränkter Nierenfunktion wird mehr aktives SDZ als SMZ ausgeschieden. In vieler Hinsicht ist Co-trimazin neben seinen Vorteilen beim normalen Patienten eindeutig besser für Patienten mit Nierenfunktionsstörungen. Auf der Basis der pharmakokinetischen Eigenschaften werden Dosierungen vorgeschlagen, die unabhängig von der Nierenfunktion annähernd dieselben Plasmaspiegel erzielen.Notes: Summary The pharmacokinetics of tablets containing combinations of sulphadiazine (SDZ) and trimethoprim (TMP) (co-trimazine) and tablets with sulphamethoxazole (SMZ) and TMP (co-trimoxazole) were compared in patients with different renal functions. In normal renal function, SMZ is more similar to TMP than in renal impairment. In renal impairment although the serum half-life (t1/2) of both active and total SDZ remains similar to that of TMP, the t1/2 of total SMZ becomes several times higher than the t1/2 of TMP. The unchanged SMZ maintains approximately the same elimination velocity in reduced as in normal renal function. Consequently, for co-trimoxazole there is a buildup of SMZ metabolites which can only contribute to toxicity for co-trimoxazole, whereas the co-trimazine components have t1/2 values of the same order, also in renal dysfunction. The distribution volumes of SDZ, SMZ or TMP are the same regardless of renal function. However, the distribution volume of SDZ is closer to that of TMP, i. e. higher than the SMZ values. More active SDZ is excreted in the urine than SMZ both in normal and in reduced renal function. Thus co-trimazine, in addition to having some advantages in the normal individual, is in many respects distinctly more suitable in patients with renal functional impairment. On the basis of the pharmacokinetic properties, dosage schedules are suggested that will give approximately the same plasma levels regardless of renal function.Type of Medium: Electronic ResourceURL: